84
Views
1
CrossRef citations to date
0
Altmetric
Reflections and scientific reviews from established women scientists

Targeting of radio-enhancing drugs

Pages 461-465 | Received 22 Jun 2021, Accepted 24 Oct 2021, Published online: 02 Dec 2021

References

  • Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H. 2008. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol. 15(10):2887–2893.
  • Berrada M, Yang Z, Lehnert S. 2004. Sensitization to radiation from an implanted 125I source by sustained intratumoral release of chemotherapeutic drugs. Radiat Res. 162(1):64–70.
  • Berrada M, Yang Z, Lehnert S. 2002. Tumor treatment by sustained intratumoral release of 5-fluorouracil: effects of drug alone and in combined treatments. Int J Radiat Oncol Biol Phys. 54(5):1550–1557.
  • Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G, et al. 1995. Placebo-controlled trial of safety and efficacy of intra-operative controlled delivery by biodegradable polymer of chemotherapy for recurrent gliomas. Lancet. 345(8956):1008–1012.
  • Chattopadhyay N, Cai Z, Kwon YL, Lechtman E, Pignol J-P, Reilly RM. 2013. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Res Treat. 137(1):81–91.
  • Chen Y, Yang Y, Fu S, Fu J. 2020. Gold nanoparticles as radiosensitizers in cancer radiotherapy. Int J Nanomedicine. 15(15):9407–9430.
  • Doiron A, Yapp D, Olivares M, Zhu J, Lehnert S. 1999. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine. Cancer Res. 59(15):3677–3681.
  • Haume K, Rosa S, Grellet S, Śmiałek MA, Butterworth KT, Solov’yov AV, Prise KM, Golding J, Mason NJ. 2016. Gold nanoparticles for cancer radiotherapy: a review. Cancer Nano. 7(1):1–20.
  • Jeong S-Y, Park S-J, Yoon SM, Jung J, Woo HN, Yi SL, Song SY, Park HJ, Kim C, Lee JS, et al. 2009. Systemic delivery and preclinical evaluation of Au nanoparticle containing beta-lapachone for radiosensitization. J Control Release. 139(3):239–245.
  • Jones GDD, Ward JF, Limoli CL, Moyer DJ, Aguilera JA. 1995. Mechanisms of radio-sensitization in iododeoxyuridine-substituted cells. Int J Radiat Biol. 67(6):647–653.
  • Kirichenko AV, Rich TA, Newman RA, Travis E. 1997. Potentiation of murine Mca-4 carcinoma response by 9-amino-20(s) camptothecin. Cancer Res. 57(10):1929–1933.
  • Lawrence TS, Davis MA, Maybaum J, Stetson PL, Ensminger WD. 1990. The dependence of halogen pyrimidine incorporation and radiosensitization on the duration of drug exposure. Int J Radiat Oncol Biol Phys. 18(6):1393–1398.
  • Liu C, Wang C, Chen S. 2010. Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys Med Biol. 55:931–945.
  • Miller EM, Fowler JF, Kinsella TG. 1992. Radiosensitization by halogenated pyrimidines: radiosensitization of human colon cells by iodo-deoxyuridine substituted cells. Radiat Res. 132:81–89.
  • Nagpal S. 2012. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma. Neurosurg Clin N Am. 23(2):289–295.
  • Sipos E, Witham T, Ratan R, Baraban J, Brem H. 1995. Biothionine sulfoximine potentiates the antitumor effect of 4-hydroxycyclophosphamide when deliver locally in the intracranial 9L-glioma model. Proc Am Assoc Cancer Res. 36:308.
  • Skowronek J. 2017. Current status of brachytherapy in cancer treatment – short overview. J Contemp Brachyther. 9(6):581–589.
  • Uhl V, Phillips TL, Ross GY, Bodell WJ, Rasmussen J. 2008. Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines. Int J Radiat Oncol Biol Phys. 22(3):489–494.
  • Walter K, Kahan M, Gur A, Tyler B, Hilton J, Colvin O. 1994. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res. 54:2207–2212.
  • Williams JA, Yuan X, Dillehay LE, Shastri VR, Brem H, Williams JR. 1998. Synthetic implantable polymers for local delivery of IUDR in experimental, malignant human glioma. Int J Radiat Oncol Biol Phys. 42(3):631–639.
  • Yapp D, Lloyd D, Zhu J, Lehnert S. 1997. Tumor treatment by sustained intratumoral release of cisplatin: effects of drug alone and combined with radiation. Int J Radiat Oncol Biol Phys. 39(2):497–504.
  • Yapp DT, Lloyd DK, Zhu J, Lehnert S. 1999. Radiosensitization of a mouse tumor model by sustained intra-tumoral release of etanidazole and tirapazamine using a biodegradable polymer implant device. Radiother Oncol. 53(1):77–84.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.